Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Joseph Jimenez
Age : 61
Public asset : 8,237,123 USD
Country of residence : Unknown
Linked companies : The Procter & Gamble Company - General Motors Company - Graphite Bio, Inc. - Century Therapeutics, Inc.

Biography of Joseph Jimenez 
Mr. Joseph Jimenez is an Independent Director at Graphite Bio, a Chairman at Century Therapeutics LLC, a Director & Managing Director at Aditum Bio Fund 1 LP, an Independent Director at Procter & Gamble Co., an Independent Director at General Motors Co. and a President at European Federation of Pharmaceutical Industries & Assns. He is on the Board of Directors at Graphite Bio, Aditum Bio Fund 1 LP, Procter & Gamble Co. and General Motors Co. Mr. Jimenez was previously employed as a Chairman-Elect by Pharmaceutical Research & Manufacturers of America, an Independent Director by Colgate-Palmolive Co., a Chairman by Speedel Holding AG, a General Director by Novartis Pharma Schweiz AG, a Chief Executive Officer by Novartis AG, a Chief Executive Officer by Novartis Consumer Health, Inc., a Non-Executive Director by AstraZeneca Plc, an Executive Vice President by H.J. Heinz Co., a President, Chief Executive Officer & Executive VP by Heinz Europe Ltd., a President & Chief Executive Officer by Heinz North America Consumer Products, a President- & Senior Vice President by ConAgra Foods, Inc., a Chief Executive Officer by Novartis Pharmaceuticals Corp., and a Chairman by Speedel Pharma AG. He also served on the board at uBiome, Inc., Blue Nile, Inc., Pinnacle Foods Finance LLC and Pinnacle Foods Group LLC. He received his undergraduate degree from Stanford University and an MBA from the University of California, Berkeley.


Current positions of Joseph Jimenez 
Holdings of Joseph Jimenez 
Joseph Jimenez : Personal Network 
Most Read News 
01/13Investor Peltz, corporate doctor, pushes Disney to take bitter pill
RE
01/25Musk says China rivals 'work hardest, smartest'
RE
01/13Musk bets big on beating shareholders at 'funding secured' trial
RE
01/19Ark's Wood remains bullish on Tesla, says oil stock rally 'defying logic'
RE
01/26LVMH's Arnault brushes off succession question
RE
01/19JPMorgan CEO Dimon sees interest rates going beyond 5% - CNBC
RE
01/23Musk to return to stand in fraud trial over 2018 Tesla tweet
RE
01/19Sacked GM workers in India sue company, CEO Barra for unpaid compensation
RE
01/20Musk expected to take stand as trial resumes over Tesla tweet
RE
01/26Wells Fargo CEO Scharf's 2022 pay unchanged at $24.5 million
RE
More news


© 2023 People and Ownership :   
Joseph Jimenez : Connections 


Latest news about Joseph Jimenez 
2022The Procter & Gamble Company Elects Rajesh Subramaniam to its Board of Directors
CI
2022The Procter & Gamble Company Announces Board Changes
CI
2022Procter & Gamble Names Moeller Chairman as Taylor Retires
DJ
2020Novartis AG : Back to basics
MS
2018The Procter & Gamble Company Announces Board Appointments
CI
2018Transcript : Novartis AG, Q4 2017 Earnings Call, Jan 24, 2018
CI
2017P&G appoints Peltz to board despite losing proxy battle
RE
More news